Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb 2;336(7638):251-4.
doi: 10.1136/bmj.39434.500185.25.

Value based pricing for NHS drugs: an opportunity not to be missed?

Karl Claxton  1 , Andrew Briggs, Martin J Buxton, Anthony J Culyer, Christopher McCabe, Simon Walker, Mark J Sculpher
Affiliations

Value based pricing for NHS drugs: an opportunity not to be missed?

Karl Claxton et al. BMJ. .

Abstract

The policy debate about price, value, and innovation in pharmaceuticals is at a critical stage for the NHS. Claxton and colleagues describe the key principles of value based pricing and consider some of the concerns about such a scheme

PubMed Disclaimer

Conflict of interest statement

Competing interests: AJC chairs NICE’s research and development advisory committee, for which the University of York receives payment.

Figures

None
Fig 1 Value, price, and cost effectiveness
None
Fig 2 Price, guidance, and volume
See this image and copyright information in PMC

Comment in

  • PPRS: Not dead yet.
    Furniss J. Furniss J. BMJ. 2008 Feb 23;336(7641):406. doi: 10.1136/bmj.39489.635556.BE. BMJ. 2008. PMID: 18292147 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Office of Fair Trading. The pharmaceutical price regulation scheme. An OFT market study London: Office of Fair Trading, 2007. www.oft.gov.uk/shared_oft/reports/comp_policy/oft885.pdf
    1. Collier J. The pharmaceutical price regulation scheme. BMJ 2007;334:435-6. - PMC - PubMed
    1. Department of Business Enterprise and Regulatory Reform. Interim government response to Office of Fair Trading (OFT) market study on PPRS London: Department of Business Enterprise and Regulatory Reform, 2007. (URN 07/1247.) www.berr.gov.uk/files/file40756.pdf
    1. National Institute for Health and Clinical Excellence. First report of the health committee 2007-2008. London: Stationery Office, 2008. (HC27-I.)
    1. Collier J. Parliamentary review asks NICE to do better still. BMJ 2008;336:56-7. - PMC - PubMed

Publication types

Substances